Why has CSL (ASX:CSL) been in news recently?

September 30, 2022 06:15 PM AEST | By Sonal Goyal

Image source: © Timonschneider | Megapixl.com

CSL to invest up to AU$500,000 in seven medical programs

On 27 September 2022, CSL shared via a media release that CSL Research Acceleration Initiative (RAI) partnership has been awarded to seven medical researchers. RAI helps in establishing partnerships between global research organisations and CSL to speed up the commercialisation of discovery programs.

Reportedly, maximum AU$500,000 would be invested in each program for two years. The investment would be made to accelerate the discovery of innovative biotherapies.

The company has selected the seven awardees through the 2021 call for proposals. It includes researchers from the University of Basel in Switzerland, Justus Liebig University Giessen and University Hospital of Ludwig Maximilian University of Munich in Germany, the University of Pennsylvania in the US, the University of Newcastle and ANZAC Research Institute in Australia and The University of Queensland.

According to the media release, the research of selected global RAI awardees helps in addressing unmet medical needs such as metabolic and cardiovascular diseases, respiratory, transplant and immunology.

Here's the list of selected medical researchers.

Allison Pettit is a professor at the University of Queensland. Pettit's program intends to improve the engraftment and homing of hematopoietic stem cell transplants.
Kristen Coupland from the University of Newcastle investigates novel therapeutic targets for acute ischemic stroke.
Georgina Clark, an associate professor at ANZAC Research Institute, aims to develop a treatment that could decrease the need for chemotherapy during hematopoietic stem cell transplants.
Daniel Rader, a professor at the University of Pennsylvania, intends to introduce therapy for decreasing triglycerides in the blood.
The research program of Elie El Agha, professor at Justus Liebig University Giessen, is focused on a lung disease that does not have any cure.
The research by Arthur Liesz, professor at the University Hospital of Ludwig Maximilian University of Munich, would examine the interplay between the brain and immune system.
Daniel Ricklin, a professor at the University of Basel, is focused on developing an approach that could be used in multiple serious diseases.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.